(Q51553902)

7 April 2018

title

Screening for Type 2 diabetes mellitus: a decision analytic approach. (English)

1 reference

7 April 2018

0 references

Goyder EC

1

1 reference

7 April 2018

Irwig LM

series ordinal

2

1 reference

7 April 2018

publication date

1 June 2000

1 reference

7 April 2018

published in

Diabetic Medicine

1 reference

7 April 2018

volume

17

1 reference

7 April 2018

issue

6

1 reference

7 April 2018

page(s)

469-477

1 reference

7 April 2018

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00308.X

Population screening for diabetes mellitus. Professional Advisory Committee of the British Diabetic Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00308.X

Using decision analysis to compare policies for antenatal screening for Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00308.X

Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00308.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00308.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00308.X

Model of complications of NIDDM. I. Model construction and assumptions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00308.X

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00308.X

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00308.X

Evaluation of Fasting Plasma Glucose as Screening Test for NIDDM in Older Adults: Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00308.X

Effectiveness of glycosylated hemoglobin, fasting plasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00308.X

Utility approach to measuring health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00308.X

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00308.X

Screening for prostate cancer. A decision analytic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00308.X

Primer on Medical Decision Analysis: Part 5—Working with Markov Processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2000.00308.X

10.1046/J.1464-5491.2000.00308.X

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018